Department of Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden.
OncoRay - National Center for Radiation Research in Oncology (NCRO), Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, and Helmholtz-Zentrum Dresden-Rossendorf, Fetscherstrasse 74, 01307 Dresden.
Nat Rev Cancer. 2016 Apr;16(4):234-49. doi: 10.1038/nrc.2016.18. Epub 2016 Mar 18.
Technological advances and clinical research over the past few decades have given radiation oncologists the capability to personalize treatments for accurate delivery of radiation dose based on clinical parameters and anatomical information. Eradication of gross and microscopic tumours with preservation of health-related quality of life can be achieved in many patients. Two major strategies, acting synergistically, will enable further widening of the therapeutic window of radiation oncology in the era of precision medicine: technology-driven improvement of treatment conformity, including advanced image guidance and particle therapy, and novel biological concepts for personalized treatment, including biomarker-guided prescription, combined treatment modalities and adaptation of treatment during its course.
在过去几十年中,技术进步和临床研究使放射肿瘤学家能够根据临床参数和解剖信息为患者量身定制精确的放射剂量治疗方案。许多患者都能在保留与健康相关的生活质量的同时,消灭肿瘤的宏观和微观病灶。在精准医疗时代,两种主要策略的协同作用将进一步扩大放射肿瘤学的治疗窗口:一是通过先进的图像引导和粒子治疗等技术驱动的治疗方式改进,提高治疗的一致性;二是通过生物标志物指导的处方、联合治疗方式和治疗过程中的调整等个性化治疗的新生物学概念。